Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2
diabetes mellitus (T2DM), particularly in low-and middle-income countries. To effectively …

Patients with type 2 diabetes are at high risk for development of cardiovascular disease,
including myocardial infarction, stroke, heart failure, and cardiovascular death. Multiple large …

Due to their cardiovascular protective effect, glucagon-like peptide-1 receptor agonists (GLP-
1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) represent breakthrough …

Patients with type 2 diabetes mellitus (T2DM) can have multiple comorbidities and
premature mortality due to atherosclerotic cardiovascular disease, hospitalization with heart …

OBJECTIVE In patients with moderate to severe albuminuric kidney disease, sodium–
glucose cotransporter 2 inhibitors reduce the risk of kidney disease progression. These post …

Background Inflammation plays a crucial role in coronary atherosclerosis progression, and
growing evidence has demonstrated that the fibrinogen-to-albumin ratio (FAR), as a novel …

Background Statins reduce LDL cholesterol and cardiovascular events among those with or
without diabetes but have been reported to increase new-onset diabetes. The CLEAR …

Background Inflammation plays a crucial role in the pathogenesis and progression of
coronary artery disease (CAD). The neutrophil to lymphocyte ratio (NLR) is a novel …

Background Previous studies has shown a significant relationship between baseline
triglyceride-glucose (TyG) index and cardiovascular disease (CVD). However, the long-term …

Green tea polyphenols have numerous functions including antioxidation and modulation of
various cellular proteins and are thus beneficial against metabolic diseases including …